Skip to main content
. 2023 Oct 5;18(10):e0287766. doi: 10.1371/journal.pone.0287766

Fig 4. Latent-class model mean preference results and 95% CIs: Class 2 (Class% = 28.9).

Fig 4

CIs = Confidence intervals; IV = Intravenous; CAR-T = Chimeric Antigen Receptor; BiTE® = Bispecific T-Cell Engager; ADC = Anti-Drug Conjugate PFS = Progression-free survival; GI = Gastrointestinal, CNS = Central Nervous System; CRS = Cytokine Release Syndrome. Class% is the average probability of classification into the class across respondents.